Page last updated: 2024-08-21

vancomycin and Coronary Restenosis

vancomycin has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angsantikul, P; Carpenter, C; Chen, TC; Chien, S; Dehaini, D; Fang, RH; Gao, W; Hofman, FM; Hu, CM; Kroll, AV; Luk, BT; Nguyen, P; Patel, SH; Qu, V; Ramesh, M; Shi, W; Thamphiwatana, S; Wang, KC; Wen, CH; Zhang, K; Zhang, L; Zhu, J1

Other Studies

1 other study(ies) available for vancomycin and Coronary Restenosis

ArticleYear
Nanoparticle biointerfacing by platelet membrane cloaking.
    Nature, 2015, Oct-01, Volume: 526, Issue:7571

    Topics: Animals; Anti-Bacterial Agents; Blood Platelets; Blood Vessels; Cell Membrane; Collagen; Complement Activation; Coronary Restenosis; Disease Models, Animal; Docetaxel; Drug Delivery Systems; Humans; Macrophages; Male; Mice; Nanoparticles; Platelet Adhesiveness; Polymers; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Taxoids; Unilamellar Liposomes; Vancomycin

2015